Edenlux Sets U.S. Debut For Eye Strain Device

Hand holding a modern eye strain relief device with a U.S. city skyline in the background, representing Edenlux’s entry into the American market

South Korea based startup Edenlux is preparing to enter the U.S. market with Eyeary, a wearable eye strain wellness device designed for people who spend long hours on digital screens. The company plans to introduce the product through a U.S. focused crowd funding campaign.

To support its expansion, Edenlux has set up a U.S. subsidiary in Dallas, Texas. Final assembly of Eyeary units for American customers will take place locally, allowing closer quality control and faster distribution.

Eyeary looks similar to regular eyewear but works very differently. It uses a lens system with 144 diopter focal points that constantly shift focus, encouraging the eye’s ciliary muscles to stay active. This approach aims to reduce digital eye strain caused by prolonged screen use.

Key Eyeary Features

  • Lens system with continuous micro focus adjustments
  • Bluetooth connection to a companion mobile app
  • App based tracking of usage frequency and intensity
  • AI-driven personalization based on age and eye behavior

Edenlux’s Eyeary reflects a broader shift toward non medical visual wellness wearables, where reducing eye fatigue and improving long duration screen comfort are key design goals. Similar priorities are emerging in adjacent categories like AR eyewear, as seen in recent innovations focused on high refresh rates and visual ergonomics, such as the latest AR gaming glasses designed for extended digital use.

Edenlux anonymizes and processes usage data collected through the app on its servers. The company says its AI models adapt training programs based on individual needs and reported symptoms.

Company Background Snapshot

Metric Details
First product launch Otus in 2022
Lifetime revenue About $10 million
Funding raised $99 million total
Regulatory status U.S. general wellness device

Eyeary falls under the FDA’s General Wellness policy and is not regulated as a medical device. Edenlux is also developing additional wellness products for eye and sensory health, with most early releases planned for Asian markets.

Previous Article

How Investors Value AI Startups in 2026 Using Key Metrics?

Next Article

Google Pays $68M to Settle Google Assistant Privacy Lawsuit